2 completed, 2 recruiting, 1 active not recruiting, 1 terminated. 6 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 6 | Completed 2, Recruiting 2, Active not recruiting 1, Terminated 1 |
Follow Shock: new trials by email Literature Review of Shock trials Research Report on Shock
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance Giapreza - Septic Shock, Cirrhosis | Early Phase 1 | Active not recruiting | The Cleveland Clinic | 30 | 2024-11-15 | 2026-05-05 |
| Cardiac Power Output in Cardiogenic Shock Patients 1:1 Randomization to receive milrinone - Heart Failure, Cardiogenic Shock | Early Phase 1 | Recruiting | University of Chicago | 5 | 2023-07-06 | 2026-08-06 |
| Tadekinig Alfa (IL-18BP) Rescue Therapy for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like Syndrome Tadekinig alfa (IL-18BP) - CRS - Cytokine Release Syndrome, HLH | Early Phase 1 | Recruiting | University of Pennsylvania | 10 | 2022-04-17 | 2026-03-03 |
| Autonomic Nervous Activity During the Systemic Inflammatory Response in Trained and Untrained Healthy Volunteers Endotoxin, Endotoxin + Nicotine - Systemic Inflammatory Response Syndrome | Early Phase 1 | Completed | Copenhagen University Hospital, Rigshospitalet | 23 | 2012-06-01 | 2016-01-29 |
| Low Dose Vasopressin in Traumatic Shock normal saline control, vasopressin - Injuries, Shock, Traumatic | Early Phase 1 | Terminated | The University of Texas Health Science Center at San Antonio | 81 | 2007-02-01 | 2019-06-18 |
| Dose-response Study of Arginine Supplementation in Severe Sepsis L-arginine - Sepsis, Septic Shock | Early Phase 1 | Completed | Maastricht University Medical Center | 8 | 2003-10-01 | 2013-01-29 |
Shock, Septic (2) · Acute Kidney Injury (1) · Cytokine Release Syndrome (1) · Fibrosis (1) · Heart Failure (1) · Sepsis (1) · Shock, Cardiogenic (1) · Shock, Traumatic (1) · Systemic Inflammatory Response Syndrome (1) · Wounds and Injuries (1)
Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Inflammation (4) · Systemic Inflammatory Response Syndrome (3) · Infections (2) · Cardiovascular Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Heart Diseases (1) · Infarction (1) · Ischemia (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Myocardial Infarction (1)
Arginine (1) · Endotoxins (1) · Giapreza (1) · Milrinone (1) · Nicotine (1) · Nicotine Chewing Gum (1) · Tobacco Use Cessation Devices (1) · Vasopressins (1) · angiotensin II, Phe(4)- (1) · interleukin-18 binding protein (1)
Copenhagen University Hospital, Rigshospitalet (1) · Maastricht University Medical Center (1) · The Cleveland Clinic (1) · The University of Texas Health Science Center at San Antonio (1) · University of Chicago (1) · University of Pennsylvania (1)
United States (4) · Denmark (1)
Nicolaas E Deutz, MD PhD (1) · Siddharth Dugar, M.D. (1) · Stephen M. Cohn, MD (1) · Susanne Janum, MD (1) · Valluvan Jeevanandam, MD (1)